Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Homeopathic preparations versus metoprolol for mild hypertension
2012-005097-66Phase 2Terminated
- Sponsor
- Homviora
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in hypertension (HTN) comparing Homviotensin, Homvioalbin and Beloc-Zok mite (3 arms). Primary endpoint: Blood pressure effect after 6 weeks. Started Mar 2013; status: terminated.
02
Drugs
Homviotensinviscum albumCormet
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2012-005097-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005097-66.